Media

Research Capital Corporation – Additional Phase 2a Analysis by a Chronic Cough KOL
Pulmonary Fibrosis News – NP-120, Potential IPF Treatment, Stabilizes Lung Function in Trial
Streetwise Reports – Patients in Algernon’s Phase 2a Study Show Improved Lung Capacity
Share via
Copy link
Powered by Social Snap